Keeping Phase 3 clinical trials on track: strategies and solutions

Easing the complexity of Phase 3 clinical trials

Phase 3 trials are designed to confirm the effectiveness, monitor side effects, and collect data to ensure a drug is safe and efficient for use in the general population. These trials often involve large patient groups and multiple sites, making logistics and coordination complex and challenging. Any delays or excursions can lead to significant financial losses and postponed patient access to potentially life-saving treatments.

Employing a suite of solutions

Supply chain monitoring and logistics solutions play a pivotal role in helping pharma companies keep their Phase 3 clinical trials on track. Here’s how:

Real-time monitoring and analytics

Implement real-time monitoring of temperature-sensitive products, ensuring they remain within required conditions throughout the supply chain. Also, use detailed analytics and reporting, enabling proactive management and quick resolution of potential issues.

Enhanced efficiency

Automate data collection and reporting processes, reducing manual labor and the potential for human error. Furthermore, deliver end-to-end supply chain solutions that integrate seamlessly with existing systems, enhancing overall efficiency.

Compliance and quality assurance

Ensure that all logistics processes comply with international regulatory standards is imperative. Provide documentation and data necessary for regulatory audits, ensuring trial integrity and compliance.

Supply chain sustainability initiatives

By monitoring and managing the supply chain more effectively, companies can reduce waste and implement sustainable solutions to minimize the environmental impact of clinical trial logistics.

Keeping clinical trials on track

Maintaining the integrity of a Phase 3 clinical trial can be tricky; pharma companies are better served to:

• Implement centralized systems to oversee logistics across multiple trial sites.
• Ensure temperature-sensitive biological samples and drugs are stored and transported under optimal conditions.
• Utilize advanced tracking technologies to monitor the location and condition of samples and supplies.
• Leverage integrated platforms that consolidate data from various sources, facilitating better decision-making.
• Adhere to SOPs that align with regulatory requirements and conduct regular audits and inspections to ensure compliance with Good Clinical Practice (GCP) guidelines.

The role of technology in streamlining trials

Maintaining the efficiency and timeliness of Phase 3 clinical trials is a complex yet critical task for pharmaceutical companies. By adopting robust planning, efficient logistics, and advanced technologies, they can navigate the challenges and ensure the successful completion of these trials. As technology continues to evolve, the future of clinical trials looks promising, with even greater efficiencies and innovations on the horizon.

Snippet from Whitepaper: The butterfly effect: how temperature excursions impact trial timelines

Temperature excursions have a butterfly effect on clinical trials – and the consequent costs are manifold. Here are some of the areas often impacted negatively when shipment monitoring is passive:

• Time for pharma internal investigation
• Time for the quality team to prepare, communicate, and file paperwork to satisfy excursion investigations
• Time for this to be approved
• Environmental cost of discarding drugs (deemed unsafe or cleared too late to be administered)
• The need to reschedule participant visits, risking of out-of-window visits
• Cost and time of registering new participants, replacing safety follow-up of ITT population, and lost to follow-up participants
• Strain on pharma relationships with study investigators
• Protocol deviations and the cost and time of altering protocols
• Loss of access to investigational drugs
• Health cost of the delayed release

To find out more, please visit www.controlant.com

Discover how real-time tracking can protect your trial timelines and reduce costly disruptions.